Free Float 92,39 %
Shares Float 603,17 M
Shares Outstanding 652,86 M
BONE THERAPEUTICSCS S.A. Share · BE0974280126 · A14NHV (XBRU) Belgium · Healthcare — real-time prices and quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of BONE THERAPEUTICSCS S.A.
No Price
Share Float & Liquidity
Company Profile for BONE THERAPEUTICSCS S.A. Share
BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures. The company is based in Mont-Saint-Guibert, Belgium.
Company Data
Name BONE THERAPEUTICSCS S.A.
Company Bone Therapeutics S.A.
Website
https://www.biosenic.com
Primary Exchange 
EURONEXT - EURONEXT BRUSSELS
EURONEXT - EURONEXT BRUSSELS
WKN A14NHV
ISIN BE0974280126
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Miguel Forte
Country Belgium
Currency EUR
Employees 0,0 T
Address Rue Granbonpré 11 - Bâtiment H, 1435 Mont-Saint-Guibert
IPO Date 2015-02-06
Key Ratios
Valuation
P/E Ratio 0,06x
P/B Ratio -0,67x
P/S Ratio —
P/FCF Ratio —
Margins
Gross Margin —
Operating Margin —
Net Margin —
As of 24.08.2026
Dividends from 'BONE THERAPEUTICSCS S.A.'
| Ex-Date | Dividend per Share |
|---|---|
| 15.03.2022 | 0,29 EUR |
Ticker Symbols
| Name | Symbol |
|---|---|
| EURONEXT - EURONEXT BRUSSELS | BIOS.BR |
| EURONEXT - EURONEXT BRUSSELS | BOTHE.BR |
| Frankfurt | BT1.F |
| London | 0R55.L |